Why I Prefer KLA Corporation Over ASML Right Now

KLA (KLAC) was reiterated with a Buy rating, citing a superior “Quality Growth” profile and a defensive, diversified revenue base versus ASML. For Q3 FY2026, revenue rose 11% YoY, and management raised full-year growth expectations to the high teens. The firm’s process control intensity model positions KLA to compound earnings through node transitions amid secular growth from chip complexity and advanced packaging.

Analysis

KLAC reads as a relatively clean way to express the idea that semiconductor capex is shifting from headline lithography spikes toward a broader, more durable spend mix. That matters because process control is a recurring tax on node migration: when chip complexity rises, the inspection/metrology budget tends to become harder to cut than wafer-fab equipment tied to a single tool milestone. In a soft patch, that usually means KLAC deserves a premium to more cyclical peers, but not an unlimited one — if the market starts paying for quality as if it were secular software-like compounding, upside gets capped.

The second-order winner is any customer segment pushing advanced packaging, heterogeneous integration, and tighter defect tolerances, because those trends increase the content per wafer and make process control more mission-critical. The loser is the portion of the equipment stack that depends on large, irregular platform refreshes; those names can see order volatility even if the broader semiconductor cycle stays healthy. Versus ASML, KLAC looks less exposed to single-point geopolitical or customer concentration shocks, so on a relative basis KLAC should hold up better if capex broadens but doesn’t accelerate dramatically.

The main risk is not demand collapse but normalization: if memory and foundry capex pauses for a quarter or two, KLAC can still grow, but the multiple can compress faster than the fundamentals. Over the next 1-3 months, the key catalyst is whether management can keep translating guidance raises into visible backlog and margin expansion; over 6-18 months, the thesis depends on whether advanced packaging remains a durable mix tailwind rather than a one-cycle narrative. Falsifiers are a guide-down, any sign that process control intensity is peaking, or a broad semi-equipment rerating lower on WFE deceleration.

Key Decisions for Investors

• Go long KLAC on any 3-5% post-print pullback; the setup favors buying strength in a name with lower earnings volatility than the broader semi-equipment group, with a 3-6 month horizon.
• Relative-value pair: long KLAC / short ASML for a 1-3 month window if the market rewards diversified spending over concentrated lithography exposure; stop if ASML order visibility re-accelerates or KLAC guides conservatively.
• Trim higher-beta semi equipment exposure into rallies (e.g., AMAT, LRCX) and rotate part of that risk into KLAC; this expresses a preference for recurring process-control demand over more cyclical capex torque.
• Watch the next earnings print for gross margin and backlog commentary; if KLAC’s growth stays in the low-to-mid teens but the multiple expands, take partial profits because the market may have already priced the quality premium.
• If semi capex indicators roll over for two consecutive months, reduce KLAC exposure rather than shorting aggressively; the bear case is usually multiple compression, not a sharp fundamental miss.